Amar Subramanya's appointment comes as John Giannandrea, Apple's senior vice-president for machine learning and AI Strategy, prepares to step down, transitioning to an advisory role before retiring in spring 2026.
While the move may give a competitive edge over rivals like Bangladesh in the global market, several industry bodies raised concerns that many state governments may not implement it on the ground.
Even by conservative assumptions that 5 to 10 per cent of infected individuals develop long Covid, India today may be home to 50 to 100 million infected individuals -- many silently coping with breathlessness, fatigue, palpitations, brain fog, or unexplained clotting tendencies.
'We've not seen a crypto exchange come back after about 45 per cent of the value on the platform was impacted.'
Digital Connexion, a joint venture between Brookfield, Reliance Industries and Digital Realty, on Wednesday announced an investment of $11 billion till 2030 for building 1 gigawatt (Gw) state-of-the-art AI-native, purpose-built data centres in Visakhapatnam, Andhra Pradesh.
'We are expecting investment, public and private, of around Rs 40 trillion by 2029.'
The Indian steel industry is faced with a paradox: Rising demand and falling prices. Demand continues to surge as user industries gather pace, with the World Steel Association projecting around 9 per cent annual growth for India over 2025 and 2026, the year domestic demand is projected to be almost 75 million tonnes (mt) higher than in 2020.
'Once the 60-plus population hits 20 to 30 per cent of the country, the demand for elderly-care treatments will surge -- cardiac, metabolic, neurological, and musculoskeletal medicines are going to dominate the market for the next several decades.'
This innovation works by stimulating our natural organs so that it can produce and maintain the insulin balance.
India's information technology (IT) spend is projected to touch $176.3 billion in 2026, rising 10.6 per cent from 2025, and outpacing the 9.8 per cent growth expected globally, according to the latest forecast by Gartner Inc., a business and technology insights company.
The "Sky Factory" will be one of the world's largest for electric vertical take-off and landing (eVTOL), a manufacturing and assembly process to make electric aircraft that can take off, hover, and land vertically. It will put India on the "map of next-generation aviation" and marks one of the most ambitious eVTOL initiatives in the world, said a state government statement.
From January to June 2025, Kaspersky enterprise solutions blocked more than 200,000 spyware attacks on Indian organisations.
Renewables sector stole the show as Andhra Pradesh bagged investments to the tune of around Rs 13.25 trillion during the three-day CII Partnership Summit in Visakhapatnam. The sector accounted for the bulk of Rs 5.33 trillion out of the memorandum of understanding (MoUs) signed during the summit.
Adani Group said on Friday it will invest around Rs 1 trillion in various sectors of Andhra Pradesh over the next ten years, deepening its commitment in the state where it will partner with Google for an artificial intelligence (AI) hub in Visakhapatnam.
Tata Steel on Wednesday reported a 272 per cent year-on-year (Y-o-Y) jump in consolidated net profit, attributable to owners, at Rs 3,101.75 crore in the second quarter of 2025-26 (Q2FY26) led by higher sales volumes in India and planned cost takeouts across geographies.
Hinduja Group-led Ashok Leyland has posted a record consolidated net profit of ~820 crore in the second quarter of 2025-26 (FY26), up 7 per cent from ~767 crore during the same quarter last year.
Their projects are known for Italian-inspired creative façades with intricate urban elegance.
Festivals also contribute to the rise in overall automobile retail sales, says dealers association.
Vinfast sold 137 cars versus Tesla's 109 during the festive months of September and October, as BYD maintained a strong lead with over 1,100 cars sold, according to Fada data.
The US Food and Drug Administration's (USFDA)'s new draft guidelines aimed at speeding up and reducing the cost of developing biosimilars - lower-priced, near-replicas of complex biologic medicines - could significantly benefit Indian biotech companies.
© 2025 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances